CD4 and central nervous system cancer: We measured protein levels by immunoblot after 48 h treatment with 5 μM CG167 or RJS308 in the following cells: Calu-3 airway cell line, THP-1 monocytic cell line, primary human monocyte-derived macrophages (MDMs), U87 glioma cell line, Huh7 hepatoma cell line, Jurkat T cell line, and primary human CD4+ T cells that were resting or activated (Supplementary Fig. 11a–g).